EP1357924A1 - Antiviral composition made from medicinal plants for combating hiv/aids - Google Patents
Antiviral composition made from medicinal plants for combating hiv/aidsInfo
- Publication number
- EP1357924A1 EP1357924A1 EP01934241A EP01934241A EP1357924A1 EP 1357924 A1 EP1357924 A1 EP 1357924A1 EP 01934241 A EP01934241 A EP 01934241A EP 01934241 A EP01934241 A EP 01934241A EP 1357924 A1 EP1357924 A1 EP 1357924A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- aids
- compositions according
- action
- new compositions
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
- A61K36/8905—Cyperus (flatsedge)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Definitions
- Herbal antiviral compositions for combating HIV / AIDS Herbal antiviral compositions for combating HIV / AIDS.
- the invention relates to new antiviral compositions based on extracts of medicinal plants for the manufacture of virolysis, virostatic and viroextirpant drugs intended for combating the disease of Acquired Immune Deficiency Syndrome (AIDS) and its various variants.
- AIDS Acquired Immune Deficiency Syndrome
- AIDS is an infectious disease which strikes hard all the planet and particularly the African continent. AIDS has been found to be often accompanied by lymphadenopathic syndromes (biliary damage, pancreatic lesions, prolonged fever, infectious dermatoses, Kaposi's sarcoma) which in their final stage is manifested by a collapse of the subject's immune defenses.
- lymphadenopathic syndromes biliary damage, pancreatic lesions, prolonged fever, infectious dermatoses, Kaposi's sarcoma
- OAPI patent n ° 08096 issued on 08/31/1986 in the name of the Institut Pasteur We know that a virus of the same type as LAV has been identified in the USA and called HTLVIII (Sciences 1984 vol. 224 4648, 497).
- OAPI patent n ° 09043 issued to CRUZ Joseph on 03/31/1991 relates to new antiviral compositions based on extract of the plant of Mimosa Pudica LINN for therapeutic use to combat the disease of AIDS.
- the center has carried out extensive research on various diseases, mainly those considered incurable by conventional medicine. It should be noted that if the treatment is done with traditional plants, the control of patients is done by the most rigorous scientific methods, the most at the forefront of current known progress.
- METRAFAIDS relates more particularly to new antiviral compositions based on plant extracts of Momordica balsamina, Aframomum melegueta, Cyperus articulatus, Ficus iteophylla, Tamarindus indica.
- Herbaceous creeper with slender, creeping or climbing stems The flowers are axillary; the fruits are ovoid orange when ripe, with many soft spines not spicy.
- the leaves contain two acidic resins and a bitter substance, momordicin. They are rich in free vitamins C: 0.04-0.05% with or without carotene. Aminobutyric acid is also found there, which slows evolution and makes the development of the virus static.
- the extracts of the whole plant give a hypoglycaemic, anticancer action; the antibiotic activity of leaf extracts is proven.
- Abortive proteins have, in vitro and in vivo, modulating actions on the immune system.
- Rhizomatous plants with erect stem reaching 1 m to 1.50 m high.
- maniguette contains 0.30% of a yellowish essence with a pleasant, aromatic odor as well as a very bitter bitter principle: the paradol next to gingerol. Its action polarizes the action of momorcharine by increasing the evolution of the environment inhibiting and neutralizing viral proliferation.
- Aframomum are tenicidal purgatives and decocté is used for baths in cases of edema by deficiency. They have deworming properties from the roots. They play a big role in the treatment of rheumatism and lung diseases.
- the fruit contains tartaric acid (8-18%), reducing sugars (25-41%), pectin (2-3.5%), and protein (2-3%). It plays an excipient role in the composition of METRAFAIDS and makes it possible to eliminate by the stool and the urine the HIV extirpated by other drugs.
- the new composition of extracts from the plants Momordica balsamina, Aframomum melegueta, Cyperus articulatus, Ficus iteophylla, Tamarindus indica has been administered to patients suffering from Acquired Immune Deficiency Syndrome, presenting the following conditions: a ) Constitutional attacks which are of dryness often characterized by Kaposi's sarcoma of fatigue shingles (herpes zoster) of fever fungal infection diagnosed with nocturnal sweating (mouth, buttocks, genitals, others) weight loss a loss of appetite (anorexia) d) Eye disorders marked by general discomfort changes in the vision of the tasks in the eyes (floats) c) Lymphatic disorders marked by sensitivity to light (photophobia) swelling of pain f) Conditions respiratory characterized by lymphadenopathy cough shortness of breath with dysneic state e) Oral syndrome marked by congestion nasa wounds (aphthous ulcers) congestion of the sinuses of the
- NB Patients 13 and 20 were absent on certain sampling days.
- METRAFAIDS drugs containing plant extracts are carried out according to different stages. For example, the leaves and roots of the plants mentioned above are removed and reduced to powder.
- the new composition is in the form of a greenish-colored powder.
- Pharmaceutical forms can be envisaged: bare or coated tablets, capsules, breakable or non-breakable tablets, capsules.
- the dosage of the medicaments prepared from the invention varies according to the duration and the phase of the disease, the age and the weight of the subject treated.
- the patient is administered on an empty stomach three (3) teaspoons of the new composition, either daily or weekly in one or more doses;
- the medicaments according to the invention can be used in the treatment of infections with opportunistic viruses (for example herpes virus, hepatitis viruses, shingles).
- opportunistic viruses for example herpes virus, hepatitis viruses, shingles.
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SN20010001 | 2001-02-05 | ||
OASN010001 | 2001-02-05 | ||
PCT/IB2001/000972 WO2002062364A1 (en) | 2001-02-05 | 2001-05-22 | Antiviral composition made from medicinal plants for combating hiv/aids |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1357924A1 true EP1357924A1 (en) | 2003-11-05 |
EP1357924A4 EP1357924A4 (en) | 2006-05-31 |
Family
ID=29398610
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP01934241A Withdrawn EP1357924A4 (en) | 2001-02-05 | 2001-05-22 | Antiviral composition made from medicinal plants for combating hiv/aids |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP1357924A4 (en) |
WO (1) | WO2002062364A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2437761A1 (en) * | 2009-03-31 | 2012-04-11 | Erick Vidjin' Agnih Gbodossou | Water-soluble antiviral product containing momordica balsamina, for the treatment and prevention of acquired immunodeficiency syndrome (aids) and the variants thereof |
CN102131513A (en) * | 2009-03-31 | 2011-07-20 | 埃里克·维德金·阿格尼·格博多苏 | Water-soluble antiviral product containing aframomum melegueta, for treatment and prevention of acquired immunodeficiency syndrome (aids) |
EP2437765A1 (en) * | 2009-03-31 | 2012-04-11 | Erick Vidjin' Agnih Gbodossou | Water-soluble antiviral product containing cyperus articulatus, for the treatment and prevention of acquired immunodeficiency syndrome (aids) and the variants thereof |
WO2016181214A1 (en) * | 2015-05-13 | 2016-11-17 | Gbodossou Erick | Compositions and methods for the treatment of ebola virus disease |
US11413320B2 (en) | 2018-12-20 | 2022-08-16 | Morehouse School Of Medicine | Antiviral compositions and methods |
US11166999B1 (en) | 2020-08-18 | 2021-11-09 | Morehouse School Of Medicine | Method of treating coronavirus infections |
US11266723B1 (en) | 2020-08-18 | 2022-03-08 | Morehouse School Of Medicine | Methods and compositions for treating coronavirus infections |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69131253T2 (en) * | 1990-10-09 | 2000-02-24 | New York University New York | USEFUL VEGETABLE PROTEIN FOR TREATING TUMORS AND HIV INFECTIONS |
WO1994018993A1 (en) * | 1993-02-23 | 1994-09-01 | Pharmakon Usa, Inc. | Therapeutic herbal composition |
US5886029A (en) * | 1997-09-05 | 1999-03-23 | Dhaliwal; Kirpal S. | Method and composition for treatment of diabetes |
AU1657899A (en) * | 1998-12-11 | 2000-07-03 | Peya Biotech Inc. | (aframomum) seeds for improving penile activity |
-
2001
- 2001-05-22 EP EP01934241A patent/EP1357924A4/en not_active Withdrawn
- 2001-05-22 WO PCT/IB2001/000972 patent/WO2002062364A1/en active Application Filing
Non-Patent Citations (2)
Title |
---|
No further relevant documents disclosed * |
See also references of WO02062364A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP1357924A4 (en) | 2006-05-31 |
WO2002062364A1 (en) | 2002-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Baydoun et al. | Ethnopharmacological survey of medicinal plants used in traditional medicine by the communities of Mount Hermon, Lebanon | |
Haudecoeur et al. | Traditional uses, phytochemistry and pharmacological properties of African Nauclea species: A review | |
Diallo et al. | An ethnobotanical survey of herbal drugs of Gourma district, Mali | |
Rajvaidhya et al. | A review on Acacia arabica-an Indian medicinal plant | |
Maiga et al. | A survey of toxic plants on the market in the district of Bamako, Mali: traditional knowledge compared with a literature search of modern pharmacology and toxicology | |
US20100303935A1 (en) | Medicinal Composition | |
Ndenecho | Herbalism and resources for the development of ethnopharmacology in Mount Cameroon region | |
Saad | Integrating traditional Greco‐Arab and Islamic diet and herbal medicines in research and clinical practice | |
Dharani et al. | An Illustrated Guide to Medicinal Plants of East Africa | |
Kaur et al. | An overview of Tulsi (Holy basil) | |
EP1357924A1 (en) | Antiviral composition made from medicinal plants for combating hiv/aids | |
US20180235904A1 (en) | Cannabidiol compositions including mixtures and uses thereof | |
US8518435B2 (en) | Homeopathic formulation consisting of Bryonia alba and Pulsatilla spp | |
Chillemi | The complete guide to natural healing: a natural approach to healing the body and maintaining optimal health using herbal supplements, vitamins, minerals, fruits, vegetables and alternative medicine | |
Dvorakova et al. | The traditional utilization, biological activity and chemical composition of edible fern species | |
WO2021242123A1 (en) | Medicament based on extracts of eight (8) medicinal plants for covid-19 treatment | |
Mahmood et al. | Foeniculum vulgare, Solanum nigrum and Cichorium intybus: A Collectanea of Pharmacological and Clinical uses | |
OA11602A (en) | Novel therapeutic antiviral compositions for the treatment of acquired immunodeficiency syndrome (AIDS) disease and its variants. | |
Khater | Herbal and Horticultural Remedies:: Gardening for the Elderly and Physically and Mentally Disabled | |
Rayburn | Let's Get Natural with Herbs | |
Saad et al. | Tradition and Perspectives of Greco‐Arab and Islamic Herbal Medicine | |
Tahri et al. | Traditional Herbal Uses from Algerian Pharmacopoeia against Infectious Diseases | |
Ugiomoh et al. | Plants used in the treatment of female infertility and other related health issues in Agbor, Ika South, Delta State, Nigeria | |
Omilani | ETHNOBOTANICAL SURVEY OF THE MEDICINAL PLANTS USED IN THE TREATMENT OF SEXUALLY TRANSMITTED DISEASES IN IBADAN, OYO STATE, NIGERIA | |
Jain et al. | Biotechnological approaches to aphrodisiac plants of Rajasthan, India |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20030331 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20060419 |
|
17Q | First examination report despatched |
Effective date: 20080825 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20131202 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R079 Free format text: PREVIOUS MAIN CLASS: A61K0035780000 Ipc: A61K0036420000 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R079 Free format text: PREVIOUS MAIN CLASS: A61K0035780000 Ipc: A61K0036420000 Effective date: 20140604 |